FOXA1 and breast cancer: In a study involving 479 BC women, it has been evidenced that in ER+ patients the expression of forkhead box A1 (FOXA1), a pioneer factor which helps the recruitment of ER and AR to their response elements on the genome, was directly correlated to the presence of AR and to better outcome, providing additional knowledge about recurrence (Rangel et al., 2018a).